KNSA logo

Kiniksa Pharmaceuticals (KNSA) EBITDA

Annual EBITDA

-$25.20 M
-$37.37 M-306.95%

December 31, 2023

Summary

Performance

1-Year Change

-306.95%

3-Year Change

+83.74%

5-Year Change

+76.64%

15-Year Change

+61.46%

KNSA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.3%
KNSA annual EBITDA is higher than 47.3% of companies in Healthcare sector

High & Low

All-time High

$12.18 M
KNSA annual EBITDA is currently -306.95% below its historical high of $12.18 million

3-Year Low

-$154.28 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
KNSA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
KNSA next annual earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Annual Revenue

$270.26 M
KNSA annual revenue is $270.26 million

Annual Net Income

$14.08 M
KNSA annual net profit is $14.08 million

Annual EBIT

-$25.20 M
KNSA annual earnings before interest & taxes is -$25.20 million

Annual EPS

$0.20
KNSA annual earnings per share is $0.20

Quarterly EBITDA

-$9.26 M
-$9.57 M-3058.15%

September 30, 2024

Summary

Performance

3-Month Change

-3058.15%

1-Year Change

+10.32%

3-Year Change

+69.15%

5-Year Change

+69.06%

KNSA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.7%
KNSA quarterly EBITDA is higher than 37.7% of companies in Healthcare sector

High & Low

All-time High

$46.91 M
KNSA quarterly EBITDA is currently -119.74% below its historical high of $46.91 million

3-Year Low

-$35.46 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KNSA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
KNSA next earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

Quarterly Revenue

$112.21 M
KNSA quarterly revenue is $112.21 million

Quarterly Net Income

-$12.69 M
KNSA quarterly net profit is -$12.69 million

Quarterly EBIT

-$9.66 M
KNSA quarterly earnings before interest & taxes is -$9.66 million

Quarterly EPS

-$0.18
KNSA quarterly earnings per share is -$0.18

TTM EBITDA

-$24.40 M
+$1.06 M+4.18%

September 30, 2024

Summary

Performance

3-Month Change

+4.18%

1-Year Change

-45.01%

3-Year Change

+85.74%

5-Year Change

+85.47%

KNSA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.18%
KNSA TTM EBITDA is higher than 46.18% of companies in Healthcare sector

High & Low

All-time High

$40.40 M
KNSA TTM EBITDA is currently -160.39% below its historical high of $40.40 million

3-Year Low

-$154.28 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
KNSA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
KNSA next earnings announcement is scheduled for Feb 28, 2025

OtherKNSAprofitabilitymetrics:

TTM Revenue

$384.10 M
KNSA TTM revenue is $384.10 million

TTM Net Income

-$9.07 M
KNSA TTM net profit is -$9.07 million

TTM EBIT

-$26.24 M
KNSA TTM earnings before interest & taxes is -$26.24 million

TTM EPS

-$0.14
KNSA TTM earnings per share is -$0.14

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$25.20 M
KNSA annual EBITDA is -$25.20 million

Annual Net Income

$14.08 M
KNSA annual net profit is $14.08 million

Annual Interest Expense

-
KNSA annual interest expense value is unknown

Annual Income Tax

-$30.74 M
KNSA annual income tax is -$30.74 million

Annual D&A

$2.34 M
KNSA annual depreciation & amortization is $2.34 million

KNSA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-306.9%+10.3%-45.0%
3 y3 years+83.7%+69.2%+85.7%
5 y5 years+76.6%+69.1%+85.5%

KNSA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-306.9%+83.7%-119.7%+73.9%-160.4%+84.2%
5 y5-year-306.9%+85.0%-119.7%+82.3%-160.4%+86.7%
alltimeall time-306.9%+85.0%-119.7%+86.2%-160.4%+86.7%

Kiniksa Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.26 M(-3058.1%)
-$24.40 M(-4.2%)
Jun 2024
-
$313.00 K(-101.9%)
-$25.47 M(-10.1%)
Mar 2024
-
-$16.08 M(-2688.7%)
-$28.33 M(+24.0%)
Dec 2023
-$25.20 M(-306.9%)
$621.00 K(-106.0%)
-$22.86 M(+35.8%)
Sep 2023
-
-$10.32 M(+304.5%)
-$16.83 M(-141.6%)
Jun 2023
-
-$2.55 M(-75.9%)
$40.40 M(+66.7%)
Mar 2023
-
-$10.60 M(-259.4%)
$24.24 M(+99.1%)
Dec 2022
$12.18 M(-107.9%)
$6.65 M(-85.8%)
$12.18 M(-140.7%)
Sep 2022
-
$46.91 M(-350.6%)
-$29.94 M(-72.0%)
Jun 2022
-
-$18.72 M(-17.4%)
-$106.85 M(-16.5%)
Mar 2022
-
-$22.66 M(-36.1%)
-$127.97 M(-17.1%)
Dec 2021
-$154.28 M(-0.4%)
-$35.46 M(+18.2%)
-$154.28 M(-9.9%)
Sep 2021
-
-$30.01 M(-24.7%)
-$171.15 M(-6.8%)
Jun 2021
-
-$39.84 M(-18.6%)
-$183.71 M(+4.9%)
Mar 2021
-
-$48.97 M(-6.4%)
-$175.14 M(+13.0%)
Dec 2020
-$154.96 M
-$52.33 M(+22.9%)
-$154.96 M(+15.1%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$42.57 M(+36.2%)
-$134.64 M(+10.4%)
Jun 2020
-
-$31.27 M(+8.6%)
-$122.00 M(-5.8%)
Mar 2020
-
-$28.79 M(-10.1%)
-$129.51 M(-22.9%)
Dec 2019
-$167.90 M(+55.6%)
-$32.02 M(+7.0%)
-$167.90 M(-6.6%)
Sep 2019
-
-$29.92 M(-22.8%)
-$179.76 M(+2.1%)
Jun 2019
-
-$38.78 M(-42.3%)
-$175.99 M(+10.9%)
Mar 2019
-
-$67.18 M(+53.1%)
-$158.72 M(+47.1%)
Dec 2018
-$107.87 M(+65.0%)
-$43.88 M(+67.8%)
-$107.88 M(+11.6%)
Sep 2018
-
-$26.15 M(+21.5%)
-$96.70 M(+11.4%)
Jun 2018
-
-$21.52 M(+31.7%)
-$86.79 M(+13.2%)
Mar 2018
-
-$16.33 M(-50.1%)
-$76.66 M(+17.3%)
Dec 2017
-$65.37 M(+172.6%)
-$32.70 M(+101.4%)
-$65.37 M(+100.1%)
Sep 2017
-
-$16.24 M(+42.6%)
-$32.67 M(+98.9%)
Jun 2017
-
-$11.39 M(+125.8%)
-$16.43 M(+225.8%)
Mar 2017
-
-$5.04 M
-$5.04 M
Dec 2016
-$23.98 M
-
-

FAQ

  • What is Kiniksa Pharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual EBITDA year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM EBITDA year-on-year change?

What is Kiniksa Pharmaceuticals annual EBITDA?

The current annual EBITDA of KNSA is -$25.20 M

What is the all time high annual EBITDA for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual EBITDA is $12.18 M

What is Kiniksa Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, KNSA annual EBITDA has changed by -$37.37 M (-306.95%)

What is Kiniksa Pharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of KNSA is -$9.26 M

What is the all time high quarterly EBITDA for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly EBITDA is $46.91 M

What is Kiniksa Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, KNSA quarterly EBITDA has changed by +$1.06 M (+10.32%)

What is Kiniksa Pharmaceuticals TTM EBITDA?

The current TTM EBITDA of KNSA is -$24.40 M

What is the all time high TTM EBITDA for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM EBITDA is $40.40 M

What is Kiniksa Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, KNSA TTM EBITDA has changed by -$7.57 M (-45.01%)